637 related articles for article (PubMed ID: 32213338)
1. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
[TBL] [Abstract][Full Text] [Related]
2. An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patients.
Koller M; Hjermstad MJ; Tomaszewski KA; Tomaszewska IM; Hornslien K; Harle A; Arraras JI; Morag O; Pompili C; Ioannidis G; Georgiou M; Navarra C; Chie WC; Johnson CD; Himpel A; Schulz C; Bohrer T; Janssens A; Kuliś D; Bottomley A
Ann Oncol; 2017 Nov; 28(11):2874-2881. PubMed ID: 28945875
[TBL] [Abstract][Full Text] [Related]
3. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
[TBL] [Abstract][Full Text] [Related]
4. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15.
Hjermstad MJ; Bergenmar M; Bjordal K; Fisher SE; Hofmeister D; Montel S; Nicolatou-Galitis O; Pinto M; Raber-Durlacher J; Singer S; Tomaszewska IM; Tomaszewski KA; Verdonck-de Leeuw I; Yarom N; Winstanley JB; Herlofson BB;
Support Care Cancer; 2016 Sep; 24(9):3915-24. PubMed ID: 27113466
[TBL] [Abstract][Full Text] [Related]
5. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
[TBL] [Abstract][Full Text] [Related]
6. Psychometric validation of the European Organisation for Research and Treatment of Cancer-Quality of Life Questionnaire Sexual Health (EORTC QLQ-SH22).
Greimel E; Nagele E; Lanceley A; Oberguggenberger AS; Nordin A; Kuljanic K; Arraras JI; Wei-Chu C; Jensen PT; Tomaszewski KA; Creutzberg CL; Galalae R; Toelen H; Zimmermann K; Bjelic-Radisic V; Costantini A; Almont T; Serpentini S; Paskeviciute Frøding L; Vistad I; Schmalz C;
Eur J Cancer; 2021 Sep; 154():235-245. PubMed ID: 34298374
[TBL] [Abstract][Full Text] [Related]
7. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in patients with lung cancer: validation of the Mexican-Spanish version and association with prognosis of the EORTC QLQ-LC13 questionnaire.
Arrieta Ó; Núñez-Valencia C; Reynoso-Erazo L; Alvarado S; Flores-Estrada D; Angulo LP; Oñate-Ocaña LF
Lung Cancer; 2012 Jul; 77(1):205-11. PubMed ID: 22387006
[TBL] [Abstract][Full Text] [Related]
9. International Psychometric Validation of an EORTC Quality of Life Module Measuring Cancer Related Fatigue (EORTC QLQ-FA12).
Weis J; Tomaszewski KA; Hammerlid E; Ignacio Arraras J; Conroy T; Lanceley A; Schmidt H; Wirtz M; Singer S; Pinto M; Alm El-Din M; Compter I; Holzner B; Hofmeister D; Chie WC; Czeladzki M; Harle A; Jones L; Ritter S; Flechtner HH; Bottomley A;
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28376231
[TBL] [Abstract][Full Text] [Related]
10. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck Module, updated version: Preliminary psychometric data from Serbian laryngectomized patients.
Trivic SK; Trivic A; Singer S; Milovanovic J; Stankovic P; Mikic A; Vukasinovic M; Djordjevic V; Jotic A; Folic M; Stevanovic D
Head Neck; 2016 Apr; 38 Suppl 1():E916-24. PubMed ID: 26189891
[TBL] [Abstract][Full Text] [Related]
11. International validation of the European Organisation for Research and Treatment of Cancer QLQ-BRECON23 quality-of-life questionnaire for women undergoing breast reconstruction.
Winters ZE; Afzal M; Rutherford C; Holzner B; Rumpold G; da Costa Vieira RA; Hartup S; Flitcroft K; Bjelic-Radisic V; Oberguggenberger A; Panouilleres M; Mani M; Catanuto G; Douek M; Kokan J; Sinai P; King MT;
Br J Surg; 2018 Feb; 105(3):209-222. PubMed ID: 29116657
[TBL] [Abstract][Full Text] [Related]
12. Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.
Ripping TM; Rammant E; Witjes JA; Aaronson NK; van Hemelrijck M; van Hoogstraten LMC; ; Kiemeney LA; Aben KKH
Health Qual Life Outcomes; 2022 Dec; 20(1):171. PubMed ID: 36581934
[TBL] [Abstract][Full Text] [Related]
13. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
14. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45.
Bjelic-Radisic V; Cardoso F; Cameron D; Brain E; Kuljanic K; da Costa RA; Conroy T; Inwald EC; Serpentini S; Pinto M; Weis J; Morag O; Lindviksmoen Astrup G; Tomaszweksi KA; Pogoda K; Sinai P; Sprangers M; Aaronson N; Velikova G; Greimel E; Arraras J; Bottomley A;
Ann Oncol; 2020 Feb; 31(2):283-288. PubMed ID: 31959345
[TBL] [Abstract][Full Text] [Related]
15. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20.
Ahmadzadeh A; Yekaninejad MS; Saffari M; Pakpour AH; Aaronson NK
Asian Pac J Cancer Prev; 2016; 17(1):255-9. PubMed ID: 26838220
[TBL] [Abstract][Full Text] [Related]
16. Independent psychometric validation of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24).
Stukan M; Zalewski K; Mardas M; Filarska D; Szajewski M; Kmieć A; Bińkowska P; Pietrzak-Stukan M; Dudziak M; Grabowski JP; Eskander RN; Greimel E
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28058740
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial Burden and Quality of Life of Lung Cancer Patients: Results of the EORTC QLQ-C30/QLQ-LC29 Questionnaire and Hornheide Screening Instrument.
Koch M; Gräfenstein L; Karnosky J; Schulz C; Koller M
Cancer Manag Res; 2021; 13():6191-6197. PubMed ID: 34393512
[TBL] [Abstract][Full Text] [Related]
18. International Phase IV Field Study for the Reliability and Validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.
Singer S; Al-Ibraheem A; Pinto M; Iakovou I; Østhus AA; Hammerlid E; Locati LD; Gamper E; Ignacio J; Jordan SJ; Kiyota N; Buettner M; Engesser D; Canotilho R; Ioannidis G; Husson O; Gama RR; Fanetti G; Moss L; Inhestern J; Andry G; Fuehrer D; Kuliś D; Rimmele H; Sykiotis G
Thyroid; 2023 Sep; 33(9):1078-1089. PubMed ID: 37450344
[No Abstract] [Full Text] [Related]
19. Reliability and validity of the Amharic version of European Organization for Research and Treatment of cervical Cancer module for the assessment of health related quality of life in women with cervical cancer in Addis Ababa, Ethiopia.
Araya LT; Gebretekle GB; Gebremariam GT; Fenta TG
Health Qual Life Outcomes; 2019 Jan; 17(1):13. PubMed ID: 30642359
[TBL] [Abstract][Full Text] [Related]
20. International validation of two EORTC questionnaires for assessment of health-related quality of life for patients with high-grade non-Hodgkin lymphoma (QLQ-NHL-HG29) and low-grade non-Hodgkin lymphoma (QLQ-NHL-LG20).
Oerlemans S; Efficace F; Kyriakou C; Freitas AC; Shamieh O; Creutzberg CL; Lehmann J; Petranovic D; Nagele E; Bredart A; Dong D; Scholz CW; Caocci G; Molica S; Griskevicius L; Xochelli A; Kieffer JM; Agelink van Rentergem JA; Alrjoub W; Mueller A; Gomes Da Silva M; Alves da Costa F; Malak S; Cocks K; van de Poll-Franse LV;
Cancer; 2023 Sep; 129(17):2727-2740. PubMed ID: 37204189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
